Form
20-F þ
|
Form
40-F o
|
Yes
o
|
No
þ
|
EXFO
ELECTRO-OPTICAL ENGINEERING INC.
|
|
By:
/s/ Germain
Lamonde
Name:
Germain Lamonde
Title:
President and Chief Executive Officer
|
|
§
|
Sales
increase 23.9% year-over-year to US$48.6 million with bookings at US$50.7
million
|
§
|
Gross
margin reaches 60.9%, highest level in seven
years
|
§
|
Navtel
Communications and Brix Networks acquisitions announced and
completed
|
Segmented
results:
|
Q3 2008 | Q2 2008 | Q3 2007 | |||||||||
(unaudited)
|
(unaudited)
|
(unaudited)
|
||||||||||
Sales:
|
||||||||||||
Telecom
Division
|
$ | 42,843 | $ | 37,435 | $ | 33,821 | ||||||
Life
Sciences and Industrial Division
|
5,738 | 5,846 | 5,384 | |||||||||
Total
|
$ | 48,581 | $ | 43,281 | $ | 39,205 | ||||||
Earnings
from operations:
|
||||||||||||
Telecom
Division
|
$ | 3,819 | $ | 2,817 | $ | 2,143 | ||||||
Life
Sciences and Industrial Division
|
639 | 818 | 697 | |||||||||
Total
|
$ | 4,458 | $ | 3,635 | $ | 2,840 | ||||||
Other
selected information:
|
||||||||||||
GAAP
net earnings
|
$ | 11,179 | $ | 4,024 | $ | 2,574 | ||||||
After-tax
amortization of intangible assets
|
$ | 791 | $ | 490 | $ | 653 | ||||||
Stock-based
compensation costs
|
$ | 334 | $ | 269 | $ | 178 | ||||||
Recognition
of previously unrecognized future income tax assets
|
$ | (5,324 | ) | $ | – | $ | – | |||||
Extraordinary
gain
|
$ | (3,036 | ) | $ | – | $ | – | |||||
Future
income tax recovery
|
$ | – | $ | (2,715 | ) | $ | – | |||||
Reduced
rate on future income tax assets
|
$ | – | $ | 1,524 | $ | – |
As
at
May
31,
2008
|
As
at
August
31,
2007
|
|||||||
(unaudited)
|
||||||||
Assets
|
||||||||
Current
assets
|
||||||||
Cash
|
$ | 8,582 | $ | 5,541 | ||||
Short-term
investments (note 2)
|
87,913 | 124,217 | ||||||
Accounts
receivable
|
||||||||
Trade,
less allowance for doubtful accounts of $241
($206
as at August 31, 2007)
|
30,100 | 26,699 | ||||||
Other
(note 2)
|
5,454 | 2,479 | ||||||
Income
taxes and tax credits recoverable (notes 3 and 9)
|
4,698 | 6,310 | ||||||
Inventories
(note 4)
|
38,098 | 31,513 | ||||||
Prepaid
expenses
|
2,282 | 1,391 | ||||||
Future
income taxes
|
9,882 | 7,609 | ||||||
187,009 | 205,759 | |||||||
Forward
exchange contracts (note 2)
|
628 | − | ||||||
Tax
credits recoverable (notes 3 and 9)
|
21,464 | − | ||||||
Property,
plant and equipment
|
21,118 | 18,117 | ||||||
Intangible
assets
|
22,264 | 9,628 | ||||||
Goodwill
|
47,285 | 28,437 | ||||||
Future
income taxes
|
16,795 | 17,197 | ||||||
$ | 316,563 | $ | 279,138 | |||||
Liabilities
|
||||||||
Current
liabilities
|
||||||||
Bank
loan
|
$ | 1,470 | $ | − | ||||
Accounts
payable and accrued liabilities (note 5)
|
23,589 | 22,721 | ||||||
Deferred
revenue
|
6,831 | 2,598 | ||||||
31,890 | 25,319 | |||||||
Deferred
revenue
|
3,815 | 3,414 | ||||||
Future
income taxes
|
− | 240 | ||||||
35,705 | 28,973 | |||||||
Contingency (note
6)
|
||||||||
Shareholders’
Equity
|
||||||||
Share
capital (note 7)
|
147,732 | 150,019 | ||||||
Contributed
surplus
|
4,985 | 4,453 | ||||||
Retained
earnings
|
56,782 | 42,275 | ||||||
Accumulated
other comprehensive income (note 2)
|
71,359 | 53,418 | ||||||
280,858 | 250,165 | |||||||
$ | 316,563 | $ | 279,138 |
Three months
ended
May
31, 2008
|
Nine
months ended
May
31, 2008
|
Three
months ended
May
31, 2007
|
Nine
months ended
May
31, 2007
|
|||||||||||||
Sales
|
$ | 48,581 | $ | 132,847 | $ | 39,205 | $ | 109,959 | ||||||||
Cost of sales (1,2)
|
19,004 | 55,208 | 16,828 | 47,027 | ||||||||||||
Gross
margin
|
29,577 | 77,639 | 22,377 | 62,932 | ||||||||||||
Operating
expenses
|
||||||||||||||||
Selling
and administrative (1)
|
15,660 | 44,160 | 12,819 | 36,545 | ||||||||||||
Net
research and development (1)
(note 8)
|
7,373 | 19,570 | 5,328 | 14,360 | ||||||||||||
Amortization
of property, plant and equipment
|
1,071 | 3,045 | 737 | 2,182 | ||||||||||||
Amortization
of intangible assets
|
1,015 | 2,469 | 653 | 2,165 | ||||||||||||
Total
operating expenses
|
25,119 | 69,244 | 19,537 | 55,252 | ||||||||||||
Earnings
from operations
|
4,458 | 8,395 | 2,840 | 7,680 | ||||||||||||
Interest
income
|
964 | 4,063 | 1,236 | 3,513 | ||||||||||||
Foreign
exchange gain (loss)
|
(59 | ) | (907 | ) | (628 | ) | 107 | |||||||||
Earnings
before income taxes and extraordinary gain
|
5,363 | 11,551 | 3,448 | 11,300 | ||||||||||||
Income taxes (note
9)
|
||||||||||||||||
Current
|
112 | (7,080 | ) | 874 | 2,509 | |||||||||||
Future
|
2,432 | 11,881 | – | – | ||||||||||||
Recognition
of previously unrecognized future income tax assets
|
(5,324 | ) | (5,324 | ) | – | – | ||||||||||
(2,780 | ) | (523 | ) | 874 | 2,509 | |||||||||||
Earnings
before extraordinary gain
|
8,143 | 12,074 | 2,574 | 8,791 | ||||||||||||
Extraordinary gain (note
3)
|
3,036 | 3,036 | – | – | ||||||||||||
Net
earnings for the period
|
$ | 11,179 | $ | 15,110 | $ | 2,574 | $ | 8,791 | ||||||||
Basic
earnings before extraordinary gain per share
|
$ | 0.12 | $ | 0.18 | $ | 0.04 | $ | 0.13 | ||||||||
Diluted
earnings before extraordinary gain per share
|
$ | 0.12 | $ | 0.17 | $ | 0.04 | $ | 0.13 | ||||||||
Basic
and diluted net earnings per share
|
$ | 0.16 | $ | 0.22 | $ | 0.04 | $ | 0.13 | ||||||||
Basic
weighted average number of shares outstanding (000’s)
|
68,907 | 68,964 | 68,917 | 68,844 | ||||||||||||
Diluted weighted average number
of shares outstanding (000’s) (note 10)
|
69,467 | 69,543 | 69,590 | 69,507 | ||||||||||||
(1)
Stock-based compensation
costs included in:
|
||||||||||||||||
Cost
of sales
|
$ | 37 | $ | 112 | $ | 32 | $ | 93 | ||||||||
Selling
and administrative
|
218 | 598 | 86 | 442 | ||||||||||||
Net
research and development
|
79 | 194 | 60 | 169 | ||||||||||||
$ | 334 | $ | 904 | $ | 178 | $ | 704 |
Comprehensive
income
|
||||||||||||||||
Three months
ended
May
31, 2008
|
Nine
months
ended
May
31, 2008
|
Three
months
ended
May
31, 2007
|
Nine
months
ended
May
31, 2007
|
|||||||||||||
Net
earnings for the period
|
$ | 11,179 | $ | 15,110 | $ | 2,574 | $ | 8,791 | ||||||||
Foreign
currency translation adjustment
|
(3,511 | ) | 16,222 | 18,067 | 7,307 | |||||||||||
Changes
in unrealized gains (losses) on short-term investments
|
(50 | ) | 40 | – | – | |||||||||||
Unrealized
gains on forward exchange contracts
|
295 | 2,844 | – | – | ||||||||||||
Reclassification
of realized gains on forward exchange contracts in net
earnings
|
(1,218 | ) | (3,145 | ) | – | – | ||||||||||
Future
income taxes effect of the above items
|
286 | 87 | – | – | ||||||||||||
Comprehensive
income
|
$ | 6,981 | $ | 31,158 | $ | 20,641 | $ | 16,098 |
Accumulated
other comprehensive income
|
||||||||
Nine
months
ended
May
31, 2008
|
Nine
months
ended
May
31, 2007
|
|||||||
Foreign
currency translation adjustment
|
||||||||
Cumulative
effect of prior periods
|
$ | 53,418 | $ | 43,537 | ||||
Current
period
|
16,222 | 7,307 | ||||||
69,640 | 50,844 | |||||||
Unrealized
gains on forward exchange contracts
|
||||||||
Adjustment
related to the implementation of new accounting standards (note
2)
|
1,948 | – | ||||||
Current
period, net of realized gains and future income taxes
|
(214 | ) | – | |||||
1,734 | – | |||||||
Unrealized
gains (losses) on short-term investments
|
||||||||
Adjustment
related to the implementation of new accounting standards (note
2)
|
(55 | ) | – | |||||
Current
period, net of future income taxes
|
40 | – | ||||||
(15 | ) | – | ||||||
Accumulated
other comprehensive income
|
$ | 71,359 | $ | 50,844 |
Retained
earnings
|
||||||||
Nine
months
ended
May
31, 2008
|
Nine
months
ended
May
31, 2007
|
|||||||
Balance
– Beginning of the period
|
$ | 42,275 | $ | − | ||||
Add
(deduct)
|
||||||||
Adjustment
related to the implementation of new accounting standards (note
2)
|
55 | − | ||||||
Net
earnings for the period
|
15,110 | 8,791 | ||||||
Premium
on redemption of share capital (note 7)
|
(658 | ) | − | |||||
Balance
– End of the period
|
$ | 56,782 | $ | 8,791 |
Contributed
surplus
|
||||||||
Nine
months
ended
May
31, 2008
|
Nine
months
ended
May
31, 2007
|
|||||||
Balance
– Beginning of the period
|
$ | 4,453 | $ | 3,776 | ||||
Add
(deduct)
|
||||||||
Stock-based
compensation costs
|
919 | 687 | ||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
(387 | ) | (221 | ) | ||||
Balance
– End of the period
|
$ | 4,985 | $ | 4,242 |
Three
months ended
May
31, 2008
|
Nine
months ended
May
31, 2008
|
Three
months ended
May
31, 2007
|
Nine
months ended
May
31, 2007
|
|||||||||||||
Cash
flows from operating activities
|
||||||||||||||||
Net
earnings for the period
|
$ | 11,179 | $ | 15,110 | $ | 2,574 | $ | 8,791 | ||||||||
Add
(deduct) items not affecting cash
|
||||||||||||||||
Discount
on short-term investments
|
533 | 1,521 | (190 | ) | 588 | |||||||||||
Stock-based
compensation costs
|
334 | 904 | 178 | 704 | ||||||||||||
Amortization
|
2,086 | 5,514 | 1,390 | 4,347 | ||||||||||||
Unrealized
losses on short-term investments
|
– | – | 70 | 70 | ||||||||||||
Gain
on disposal of capital assets
|
– | – | (100 | ) | (100 | ) | ||||||||||
Deferred
revenue
|
(937 | ) | (435 | ) | (75 | ) | 1,164 | |||||||||
Government
grants
|
– | – | − | (22 | ) | |||||||||||
Future
income taxes
|
(2,892 | ) | 6,557 | − | − | |||||||||||
Extraordinary
gain
|
(3,036 | ) | (3,036 | ) | − | − | ||||||||||
7,267 | 26,135 | 3,847 | 15,542 | |||||||||||||
Change
in non-cash operating items
|
||||||||||||||||
Accounts
receivable
|
(326 | ) | (145 | ) | (3,015 | ) | (6,260 | ) | ||||||||
Income
taxes and tax credits
|
(1,789 | ) | (11,437 | ) | (466 | ) | (1,397 | ) | ||||||||
Inventories
|
(3,585 | ) | (2,878 | ) | (2,503 | ) | (2,632 | ) | ||||||||
Prepaid
expenses
|
(110 | ) | (506 | ) | (224 | ) | (89 | ) | ||||||||
Accounts
payable and accrued liabilities
|
(116 | ) | (3,075 | ) | (231 | ) | 2,541 | |||||||||
1,341 | 8,094 | (2,592 | ) | 7,705 | ||||||||||||
Cash
flows from investing activities
|
||||||||||||||||
Additions
to short-term investments
|
(235,160 | ) | (644,220 | ) | (236,286 | ) | (726,789 | ) | ||||||||
Proceeds
from disposal and maturity of short-term investments
|
277,791 | 686,371 | 235,446 | 718,362 | ||||||||||||
Additions
to capital assets (1)
|
(1,370 | ) | (5,056 | ) | (1,890 | ) | (3,536 | ) | ||||||||
Net
proceeds from disposal of capital assets
|
– | – | 1,563 | 2,791 | ||||||||||||
Business
combinations, net of cash acquired (note 3)
|
(40,938 | ) | (40,938 | ) | − | − | ||||||||||
323 | (3,843 | ) | (1,167 | ) | (9,172 | ) | ||||||||||
Cash
flows from financing activities
|
||||||||||||||||
Change
in bank loan
|
786 | 1,485 | − | − | ||||||||||||
Repayment
of long-term debt
|
– | – | (27 | ) | (78 | ) | ||||||||||
Redemption
of share capital (note 7)
|
(3,219 | ) | (3,393 | ) | − | − | ||||||||||
Exercise
of stock options
|
51 | 61 | 90 | 573 | ||||||||||||
(2,382 | ) | (1,847 | ) | 63 | 495 | |||||||||||
Effect
of foreign exchange rate changes on cash
|
89 | 637 | 596 | 127 | ||||||||||||
Change
in cash
|
(629 | ) | 3,041 | (3,100 | ) | (845 | ) | |||||||||
Cash
– Beginning of period
|
9,211 | 5,541 | 9,108 | 6,853 | ||||||||||||
Cash
– End of period
|
$ | 8,582 | $ | 8,582 | $ | 6,008 | $ | 6,008 |
1.
|
Interim
financial information
|
2.
|
New
accounting standards and
pronouncements
|
3.
|
Business
combinations
|
(unaudited)
|
||||
Assets
acquired, net of cash acquired
|
||||
Accounts
receivable
|
$ | 776 | ||
Inventories
|
447 | |||
Other
current assets
|
320 | |||
Tax
credits
|
7,397 | |||
Core
technology
|
2,919 | |||
Future
income tax assets
|
8,351 | |||
Current
liabilities assumed
|
||||
Accounts
payable and accrued liabilities
|
(431 | ) | ||
Deferred
revenue
|
(523 | ) | ||
Future
income tax liabilities
|
(2,825 | ) | ||
Net
identifiable assets acquired
|
16,431 | |||
Purchase
price, net of cash acquired
|
11,332 | |||
Excess
of the fair value of net identifiable assets acquired over the
purchase price
|
$ | (5,099 | ) |
(unaudited)
|
||||
Assets
acquired, net of cash acquired
|
||||
Accounts
receivable
|
$ | 1,106 | ||
Inventories
|
1,229 | |||
Other
current assets
|
488 | |||
Property,
plant and equipment
|
1,097 | |||
Core
technology
|
13,765 | |||
Future
income tax assets
|
1,641 | |||
Current
liabilities assumed
|
||||
Accounts
payable and accrued liabilities
|
(2,565 | ) | ||
Deferred
revenue
|
(4,120 | ) | ||
Net
identifiable assets acquired
|
12,641 | |||
Goodwill
|
17,043 | |||
Purchase
price, net of cash acquired
|
$ | 29,684 |
4.
|
Inventories
|
As
at
May
31,
2008
|
As
at
August
31,
2007
|
|||||||
(unaudited)
|
||||||||
Raw
materials
|
$ | 18,079 | $ | 16,898 | ||||
Work
in progress
|
2,208 | 1,387 | ||||||
Finished
goods
|
17,811 | 13,228 | ||||||
$ | 38,098 | $ | 31,513 |
5.
|
Accounts
payable and accrued liabilities
|
As
at
May 31, 2008
|
As
at
August 31, 2007
|
|||||||
(unaudited)
|
||||||||
Trade
|
$ | 9,573 | $ | 11,749 | ||||
Salaries
and social benefits
|
8,670 | 7,929 | ||||||
Warranty
|
965 | 800 | ||||||
Commissions
|
782 | 824 | ||||||
Tax
on capital
|
903 | 524 | ||||||
Restructuring
charges payable
|
620 | – | ||||||
Business
combinations (note 3)
|
78 | – | ||||||
Other
|
1,998 | 895 | ||||||
$ | 23,589 | $ | 22,721 |
Nine
months
ended
May
31, 2008
|
Nine
months
ended
May
31, 2007
|
|||||||
(unaudited)
|
||||||||
Balance – Beginning of the
period
|
$ | 800 | $ | 1,006 | ||||
Provision
|
470 | 597 | ||||||
Addition from business combinations
|
175 | – | ||||||
Settlements
|
(480 | ) | (748 | ) | ||||
Balance – End of the
period
|
$ | 965 | $ | 855 |
6.
|
Contingency
|
7.
|
Share
capital
|
|
The
following tables summarize changes in share capital for the nine months
ended May 31, 2007 and 2008:
|
Nine
months ended May 31, 2007
|
||||||||||||||||||||
Multiple
voting shares
|
Subordinate
voting shares
|
|||||||||||||||||||
Number
|
Amount
|
Number
|
Amount
|
Total
amount
|
||||||||||||||||
(unaudited)
|
||||||||||||||||||||
Balance
as at August 31, 2006
|
37,143,000 | $ | 1 | 31,609,969 | $ | 148,920 | $ | 148,921 | ||||||||||||
Exercise
of stock options
|
– | – | 41,550 | 121 | 121 | |||||||||||||||
Redemption
of restricted share units
|
– | – | 88 | – | – | |||||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
– | – | – | 47 | 47 | |||||||||||||||
Balance
as at November 30, 2006
|
37,143,000 | 1 | 31,651,607 | 149,088 | 149,089 | |||||||||||||||
Exercise
of stock options
|
– | – | 109,723 | 362 | 362 | |||||||||||||||
Redemption
of restricted share units
|
– | – | 976 | – | – | |||||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
– | – | – | 127 | 127 | |||||||||||||||
Balance
as at February 28, 2007
|
37,143,000 | 1 | 31,762,306 | 149,577 | 149,578 | |||||||||||||||
Exercise
of stock options
|
– | – | 26,825 | 90 | 90 | |||||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
– | – | – | 47 | 47 | |||||||||||||||
Balance
as at May 31, 2007
|
37,143,000 | $ | 1 | 31,789,131 | $ | 149,714 | $ | 149,715 |
Nine
months ended May 31, 2008
|
||||||||||||||||||||
Multiple
voting shares
|
Subordinate
voting shares
|
|||||||||||||||||||
Number
|
Amount
|
Number
|
Amount
|
Total
amount
|
||||||||||||||||
(unaudited)
|
||||||||||||||||||||
Balance
as at August 31, 2007
|
36,643,000 | $ | 1 | 32,361,561 | $ | 150,018 | $ | 150,019 | ||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
– | – | – | 2 | 2 | |||||||||||||||
Redemption
of share capital
|
– | – | (29,200 | ) | (135 | ) | (135 | ) | ||||||||||||
Balance
as at November 30, 2007
|
36,643,000 | 1 | 32,332,361 | 149,885 | 149,886 | |||||||||||||||
Exercise
of stock options
|
– | – | 4,000 | 10 | 10 | |||||||||||||||
Redemption
of restricted share units
|
– | – | 38,031 | – | – | |||||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
– | – | – | 209 | 209 | |||||||||||||||
Balance
as at February 29, 2008
|
36,643,000 | 1 | 32,374,392 | 150,104 | 150,105 | |||||||||||||||
Exercise
of stock options
|
– | – | 14,500 | 51 | 51 | |||||||||||||||
Redemption
of restricted share units
|
– | – | 27,839 | – | – | |||||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
– | – | – | 176 | 176 | |||||||||||||||
Redemption
of share capital
|
– | – | (560,407 | ) | (2,600 | ) | (2,600 | ) | ||||||||||||
Balance
as at May 31, 2008
|
36,643,000 | $ | 1 | 31,856,324 | $ | 147,731 | $ | 147,732 |
8.
|
Net
research and development expenses
|
Three months
ended
May
31, 2008
|
Nine
months
ended
May
31, 2008
|
Three
months
ended
May
31, 2007
|
Nine
months
ended
May
31, 2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Gross
research and development expenses
|
$ | 8,843 | $ | 23,904 | $ | 6,637 | $ | 18,085 | ||||||||
Research
and development tax credits and grants
|
(1,470 | ) | (4,334 | ) | (1,309 | ) | (3,725 | ) | ||||||||
$ | 7,373 | $ | 19,570 | $ | 5,328 | $ | 14,360 |
9.
|
Income
taxes
|
Three
months
ended
May
31, 2008
|
Nine
months
ended
May
31, 2008
|
Three
months
ended
May
31, 2007
|
Nine
months
ended
May
31, 2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Income
tax provision at combined Canadian federal and provincial statutory tax
rate
|
$ | 1,638 | $ | 3,618 | $ | 1,104 | $ | 3,616 | ||||||||
Increase
(decrease) due to:
|
||||||||||||||||
Income
taxed at different rates
|
97 | 174 | (13 | ) | 20 | |||||||||||
Non-taxable
income
|
(30 | ) | (401 | ) | (48 | ) | (143 | ) | ||||||||
Non-deductible
expenses
|
233 | 823 | 142 | 588 | ||||||||||||
Change
in tax rates (1)
|
– | 1,522 | – | 290 | ||||||||||||
Change
in tax strategy (2)
|
– | (2,715 | ) | – | – | |||||||||||
Foreign
exchange effect of translation of foreign integrated
subsidiaries
|
33 | 227 | (13 | ) | 73 | |||||||||||
Other
|
(113 | ) | 278 | (167 | ) | (127 | ) | |||||||||
Recognition
of previously unrecognized future income tax assets
(3)
|
(5,324 | ) | (5,324 | ) | – | – | ||||||||||
Utilization
of previously unrecognized future income tax assets
|
– | (1,881 | ) | (511 | ) | (2,510 | ) | |||||||||
Unrecognized
future income tax assets on temporary deductible differences and unused
tax losses and deductions
|
686 | 3,156 | 379 | 702 | ||||||||||||
$ | (2,780 | ) | $ | (523 | ) | $ | 874 | $ | 2,509 |
Current
|
$ | 112 | $ | (7,080 | ) | $ | 874 | $ | 2,509 | |||||||
Future
|
1,746 | 10,606 | 132 | 1,808 | ||||||||||||
Valuation
allowance
|
(4,638 | ) | (4,049 | ) | (132 | ) | (1,808 | ) | ||||||||
(2,892 | ) | 6,557 | – | – | ||||||||||||
$ | (2,780 | ) | $ | (523 | ) | $ | 874 | $ | 2,509 |
(1)
|
During
the second quarter of fiscal 2008, reductions to the Canadian federal
statutory tax rate, previously announced by the Canadian federal
Government, were enacted. Therefore, Canadian federal future income tax
assets decreased by $1,524,000, and generated a future income tax
expense for the same amount during the nine-month period ended
May 31, 2008.
|
(2)
|
During
the second quarter of fiscal 2008, based on new Canadian federal enacted
tax rates, the company reviewed its tax strategy for the future use of its
Canadian federal operating losses, research and development expenses,
certain timing differences and research and development tax credits to
minimize income taxes payable on future years’ taxable income,
by amending its prior year’s income tax returns to generate a net
operating loss to be carried back to prior years, which will release
previously used research and development tax credits. This resulted in an
increase of its tax-related assets of $2,715,000 and in an income tax
recovery for the same amount in the statements of earnings for the
nine-month period ended May
31, 2008.
|
(3)
|
During
the third quarter of fiscal 2008, considering the expected positive
impacts the acquisitions of Navtel Communications Inc. and Brix Networks
Inc. will have on future years’ taxable income at the United States
(federal level) and because actual taxable income in the United States is
greater than expected, management concluded that is was more likely than
not that all future income tax assets of its consolidated US group would
be recovered. Consequently, it reversed its valuation allowance against
future income tax assets in the amount of $7,617,000. The portions of the
valuation allowance that was reversed, and that was attributable to the
impacts of the acquisitions of Navtel Communications Inc. and Brix
Networks Inc., in the amount of $652,000 and $1,641,000, respectively,
were included in the purchase price allocation of the related acquired
businesses. The remaining of the reversal, in the amount of $5,324,000,
has been recorded in the income taxes in the statements of earnings for
the three and nine months ended
May 31, 2008.
|
10.
|
Earnings
per share
|
Three months
ended
May
31, 2008
|
Nine
months
ended
May
31, 2008
|
Three
months
ended
May
31, 2007
|
Nine
months
ended
May
31, 2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Basic
weighted average number of shares outstanding (000’s)
|
68,907 | 68,964 | 68,917 | 68,844 | ||||||||||||
Plus
dilutive effect of:
|
||||||||||||||||
Stock
options (000’s)
|
299 | 313 | 435 | 446 | ||||||||||||
Restricted
share units (000’s)
|
175 | 188 | 184 | 168 | ||||||||||||
Deferred
share units (000’s)
|
86 | 78 | 54 | 49 | ||||||||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,467 | 69,543 | 69,590 | 69,507 | ||||||||||||
Stock
awards excluded from the calculation of diluted weighted average number of
shares because their exercise price was greater than the average market
price of the common shares (000’s)
|
1,168 | 1,332 | 1,132 | 1,255 |
11.
|
Segment
information
|
Three
months ended May 31, 2008
|
Nine
months ended May 31, 2008
|
|||||||||||||||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
|||||||||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||||||||||
Sales
|
$ | 42,843 | $ | 5,738 | $ | 48,581 | $ | 115,643 | $ | 17,204 | $ | 132,847 | ||||||||||||
Earnings
from operations
|
$ | 3,819 | $ | 639 | $ | 4,458 | $ | 6,657 | $ | 1,738 | $ | 8,395 | ||||||||||||
Unallocated
items:
|
||||||||||||||||||||||||
Interest
income
|
964 | 4,063 | ||||||||||||||||||||||
Foreign
exchange loss
|
(59 | ) | (907 | ) | ||||||||||||||||||||
Earnings
before income taxes and extraordinary gain
|
5,363 | 11,551 | ||||||||||||||||||||||
Income
taxes recovery
|
(2,780 | ) | (523 | ) | ||||||||||||||||||||
Earnings
before extraordinary gain
|
8,143 | 12,074 | ||||||||||||||||||||||
Extraordinary
gain
|
3,036 | 3,036 | ||||||||||||||||||||||
Net
earnings for the period
|
$ | 11,179 | $ | 15,110 |
Three
months ended May 31, 2007
|
Nine
months ended May 31, 2007
|
|||||||||||||||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
|||||||||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||||||||||
Sales
|
$ | 33,821 | $ | 5,384 | $ | 39,205 | $ | 92,640 | $ | 17,319 | $ | 109,959 | ||||||||||||
Earnings
from operations
|
$ | 2,143 | $ | 697 | $ | 2,840 | $ | 5,024 | $ | 2,656 | $ | 7,680 | ||||||||||||
Unallocated
items:
|
||||||||||||||||||||||||
Interest
income
|
1,236 | 3,513 | ||||||||||||||||||||||
Foreign
exchange gain (loss)
|
(628 | ) | 107 | |||||||||||||||||||||
Earnings
before income taxes
|
3,448 | 11,300 | ||||||||||||||||||||||
Income
taxes
|
874 | 2,509 | ||||||||||||||||||||||
Net
earnings for the period
|
$ | 2,574 | $ | 8,791 |
As
at
May
31,
2008
|
As
at
August
31,
2007
|
|||||||
(unaudited)
|
||||||||
Total
assets
|
||||||||
Telecom
Division
|
$ | 155,462 | $ | 109,065 | ||||
Life
Sciences and Industrial Division
|
9,040 | 9,199 | ||||||
Unallocated
assets
|
152,061 | 160,874 | ||||||
$ | 316,563 | $ | 279,138 |
12.
|
Differences
between Canadian and U.S. GAAP
|
Three
months
ended
May
31, 2008
|
Nine
months
ended
May
31, 2008
|
Three
months
ended
May
31, 2007
|
Nine
months
ended
May
31, 2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Net
earnings for the period in accordance with Canadian GAAP
|
$ | 11,179 | $ | 15,110 | $ | 2,574 | $ | 8,791 | ||||||||
Unrealized
losses on available-for-sale securities
|
– | – | 70 | 70 | ||||||||||||
Net
earnings for the period in accordance with U.S. GAAP
|
$ | 11,179 | $ | 15,110 | $ | 2,644 | $ | 8,861 | ||||||||
Out
of which:
|
||||||||||||||||
Earnings
before extraordinary gain
|
$ | 8,143 | $ | 12,074 | $ | 2,644 | $ | 8,861 | ||||||||
Extraordinary
gain
|
$ | 3,036 | $ | 3,036 | $ | – | $ | – | ||||||||
Net
earnings for the period in accordance with U.S. GAAP
|
$ | 11,179 | $ | 15,110 | $ | 2,644 | $ | 8,861 | ||||||||
Foreign
currency translation adjustment
|
(3,313 | ) | 15,409 | 16,942 | 6,638 | |||||||||||
Changes
in unrealized gains (losses) on available-for-sale
securities
|
(50 | ) | 40 | (70 | ) | (70 | ) | |||||||||
Unrealized
gains (losses) on forward exchange contracts
|
295 | 2,844 | 4,262 | (1,531 | ) | |||||||||||
Reclassification
of realized gains on forward exchange contracts in net
earnings
|
(1,218 | ) | (3,145 | ) | 40 | (804 | ) | |||||||||
Future
income taxes effect of the above items
|
286 | 87 | – | – | ||||||||||||
Comprehensive
income under U.S. GAAP
|
$ | 7,719 | $ | 30,345 | $ | 23,818 | $ | 13,094 | ||||||||
Basic
earnings before extraordinary gain per share in accordance with U.S.
GAAP
|
$ | 0.12 | $ | 0.18 | $ | 0.04 | $ | 0.13 | ||||||||
Diluted
earnings before extraordinary gain per share in accordance with U.S.
GAAP
|
$ | 0.12 | $ | 0.17 | $ | 0.04 | $ | 0.13 | ||||||||
Basic
and diluted net earnings per share in accordance with U.S.
GAAP
|
$ | 0.16 | $ | 0.22 | $ | 0.04 | $ | 0.13 | ||||||||
Basic
weighted average number of shares outstanding (000’s)
|
68,907 | 68,964 | 68,917 | 68,844 | ||||||||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,467 | 69,543 | 69,590 | 69,507 |
As
at
May
31,
2008
|
As
at
August
31,
2007
|
|||||||
(unaudited)
|
||||||||
Shareholders’
equity in accordance with Canadian GAAP
|
$ | 280,858 | $ | 250,165 | ||||
Forward
exchange contracts (note 2)
|
– | 2,864 | ||||||
Goodwill
|
(13,510 | ) | (12,697 | ) | ||||
Future
income tax assets (note 2)
|
– | (916 | ) | |||||
Stock
appreciation rights
|
(73 | ) | (73 | ) | ||||
Shareholders’
equity in accordance with U.S. GAAP
|
$ | 267,275 | $ | 239,343 |
Share
capital
|
Contributed
surplus
|
Deficit
|
Other
capital
|
Accumulated
other comprehensive income
|
Shareholders’
equity
|
|||||||||||||||||||
(unaudited)
|
||||||||||||||||||||||||
Balance
as at August 31, 2007
|
$ | 599,519 | $ | 1,537 | $ | (416,687 | ) | $ | 4,684 | $ | 50,290 | $ | 239,343 | |||||||||||
Net
loss for the period
|
– | – | (93 | ) | – | – | (93 | ) | ||||||||||||||||
Stock-based
compensation costs
|
– | – | – | 316 | – | 316 | ||||||||||||||||||
Foreign
currency translation adjustment
|
– | – | – | – | 13,182 | 13,182 | ||||||||||||||||||
Unrealized
losses on available-for-sale securities
|
– | – | – | – | 39 | 39 | ||||||||||||||||||
Unrealized
gains on forward exchange contracts, net of realized gains and future
income taxes
|
– | – | – | – | 809 | 809 | ||||||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock
awards
|
2 | – | – | (2 | ) | – | – | |||||||||||||||||
Redemption
of share capital
|
(135 | ) | – | (39 | ) | – | – | (174 | ) | |||||||||||||||
Balance
as at November 30, 2007
|
599,386 | 1,537 | (416,819 | ) | 4,998 | 64,320 | 253,422 | |||||||||||||||||
Net
earnings for the period
|
– | – | 4,024 | – | – | 4,024 | ||||||||||||||||||
Stock-based
compensation costs
|
– | – | – | 269 | – | 269 | ||||||||||||||||||
Foreign
currency translation adjustment
|
– | – | – | – | 5,540 | 5,540 | ||||||||||||||||||
Unrealized
losses on available-for-sale securities
|
– | – | – | – | 51 | 51 | ||||||||||||||||||
Unrealized
gains on forward exchange contracts, net of realized gains and future
income taxes
|
– | – | – | – | (386 | ) | (386 | ) | ||||||||||||||||
Exercise
of stock options
|
10 | – | – | – | – | 10 | ||||||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock
awards
|
209 | – | – | (209 | ) | – | – | |||||||||||||||||
Balance
as at February 29, 2008
|
599,605 | 1,537 | (412,795 | ) | 5,058 | 69,525 | 262,930 | |||||||||||||||||
Net
earnings for the period
|
– | – | 11,179 | – | – | 11,179 | ||||||||||||||||||
Stock-based
compensation costs
|
– | – | – | 334 | – | 334 | ||||||||||||||||||
Foreign
currency translation adjustment
|
– | – | – | – | (3,313 | ) | (3,313 | ) | ||||||||||||||||
Unrealized
losses on available-for-sale securities
|
– | – | – | – | (50 | ) | (50 | ) | ||||||||||||||||
Unrealized
gains on forward exchange contracts, net of realized gains and future
income taxes
|
– | – | – | – | (637 | ) | (637 | ) | ||||||||||||||||
Exercise
of stock options
|
51 | – | – | – | – | 51 | ||||||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock
awards
|
176 | – | – | (176 | ) | – | – | |||||||||||||||||
Redemption
of share capital
|
(10,788 | ) | 7,530 | 39 | – | – | (3,219 | ) | ||||||||||||||||
Balance
as at May 31, 2008
|
$ | 589,044 | $ | 9,067 | $ | (401,577 | ) | $ | 5,216 | $ | 65,525 | $ | 267,275 |
Nine
months
ended
May 31, 2008
|
Nine
months
ended
May
31, 2007
|
|||||||
(unaudited)
|
(unaudited)
|
|||||||
Foreign
currency translation adjustment
|
||||||||
Current
period
|
$ | 15,409 | $ | 6,638 | ||||
Cumulative
effect of prior periods
|
48,397 | 39,179 | ||||||
63,806 | 45,817 | |||||||
Unrealized
gains (losses) on forward exchange contracts
|
||||||||
Current
period, net of realized gains (losses) and future income
taxes
|
(214 | ) | (2,335 | ) | ||||
Cumulative
effect of prior periods, net of future income taxes
|
1,948 | 5,451 | ||||||
1,734 | 3,116 | |||||||
Unrealized
gains (losses) on available-for-sale securities
|
||||||||
Current
period, net of future incomes taxes
|
40 | − | ||||||
Cumulative
effect of prior periods, net of future income taxes
|
(55 | ) | (70 | ) | ||||
(15 | ) | (70 | ) | |||||
$ | 65,525 | $ | 48,863 |
Three
months
ended
May
31, 2008
|
Three
months
ended
May
31, 2007
|
Nine
months
ended
May
31, 2008
|
Nine
months
ended
May
31, 2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Sales
|
$ | 48,581 | $ | 39,205 | $ | 132,847 | $ | 109,959 | ||||||||
Cost
of sales (1)
|
19,004 | 16,828 | 55,208 | 47,027 | ||||||||||||
Gross
margin
|
29,577 | 22,377 | 77,639 | 62,932 | ||||||||||||
Operating
expenses
|
||||||||||||||||
Selling
and administrative
|
15,660 | 12,819 | 44,160 | 36,545 | ||||||||||||
Net
research and development
|
7,373 | 5,328 | 19,570 | 14,360 | ||||||||||||
Amortization
of property, plant and equipment
|
1,071 | 737 | 3,045 | 2,182 | ||||||||||||
Amortization
of intangible assets
|
1,015 | 653 | 2,469 | 2,165 | ||||||||||||
Total
operating expenses
|
25,119 | 19,537 | 69,244 | 55,252 | ||||||||||||
Earnings
from operations
|
4,458 | 2,840 | 8,395 | 7,680 | ||||||||||||
Interest
income
|
964 | 1,236 | 4,063 | 3,513 | ||||||||||||
Foreign
exchange gain (loss)
|
(59 | ) | (628 | ) | (907 | ) | 107 | |||||||||
Earnings
before income taxes and extraordinary gain
|
5,363 | 3,448 | 11,551 | 11,300 | ||||||||||||
Income
taxes
|
||||||||||||||||
Current
|
112 | 874 | (7,080 | ) | 2,509 | |||||||||||
Future
|
2,432 | – | 11,881 | – | ||||||||||||
Recognition
of previously unrecognized future income tax assets
|
(5,324 | ) | – | (5,324 | ) | – | ||||||||||
(2,780 | ) | 874 | (523 | ) | 2,509 | |||||||||||
Earnings
before extraordinary gain
|
8,143 | 2,574 | 12,074 | 8,791 | ||||||||||||
Extraordinary
gain
|
3,036 | – | 3,036 | – | ||||||||||||
Net
earnings for the period
|
$ | 11,179 | $ | 2,574 | $ | 15,110 | $ | 8,791 | ||||||||
Basic
earnings before extraordinary gain
|
$ | 0.12 | $ | 0.04 | $ | 0.18 | $ | 0.13 | ||||||||
Diluted
earnings before extraordinary gain
|
$ | 0.12 | $ | 0.04 | $ | 0.17 | $ | 0.13 | ||||||||
Basic
and diluted net earnings per share
|
$ | 0.16 | $ | 0.04 | $ | 0.22 | $ | 0.13 | ||||||||
Segmented
information:
|
||||||||||||||||
Sales:
|
||||||||||||||||
Telecom
Division
|
$ | 42,843 | $ | 33,821 | $ | 115,643 | $ | 92,640 | ||||||||
Life
Sciences and Industrial Division
|
5,738 | 5,384 | 17,204 | 17,319 | ||||||||||||
$ | 48,581 | $ | 39,205 | $ | 132,847 | $ | 109,959 | |||||||||
Earnings
from operations:
|
||||||||||||||||
Telecom
Division
|
$ | 3,819 | $ | 2,143 | $ | 6,657 | $ | 5,024 | ||||||||
Life
Sciences and Industrial Division
|
639 | 697 | 1,738 | 2,656 | ||||||||||||
$ | 4,458 | $ | 2,840 | $ | 8,395 | $ | 7,680 | |||||||||
Research
and development data:
|
||||||||||||||||
Gross
research and development
|
$ | 8,843 | $ | 6,637 | $ | 23,904 | $ | 18,085 | ||||||||
Net
research and development
|
$ | 7,373 | $ | 5,328 | $ | 19,570 | $ | 14,360 |
(1)
|
The
cost of sales is exclusive of amortization, shown
separately.
|
Three
months
ended
May
31, 2008
|
Three
months
ended
May
31, 2007
|
Nine
months
ended
May
31, 2008
|
Nine
months
ended
May
31, 2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Sales
|
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||||||
Cost
of sales (1)
|
39.1 | 42.9 | 41.6 | 42.8 | ||||||||||||
Gross
margin
|
60.9 | 57.1 | 58.4 | 57.2 | ||||||||||||
Operating
expenses
|
||||||||||||||||
Selling
and administrative
|
32.2 | 32.7 | 33.2 | 33.2 | ||||||||||||
Net
research and development
|
15.2 | 13.6 | 14.7 | 13.0 | ||||||||||||
Amortization
of property, plant and equipment
|
2.2 | 1.9 | 2.3 | 2.0 | ||||||||||||
Amortization
of intangible assets
|
2.1 | 1.7 | 1.9 | 2.0 | ||||||||||||
Total
operating expenses
|
51.7 | 49.9 | 52.1 | 50.2 | ||||||||||||
Earnings
from operations
|
9.2 | 7.2 | 6.3 | 7.0 | ||||||||||||
Interest
income
|
1.9 | 3.2 | 3.1 | 3.2 | ||||||||||||
Foreign
exchange gain (loss)
|
(0.1 | ) | (1.6 | ) | (0.7 | ) | 0.1 | |||||||||
Earnings
before income taxes and extraordinary gain
|
11.0 | 8.8 | 8.7 | 10.3 | ||||||||||||
Income
taxes
|
||||||||||||||||
Current
|
0.2 | 2.2 | (5.3 | ) | 2.3 | |||||||||||
Future
|
5.0 | – | 8.9 | – | ||||||||||||
Recognition
of previously unrecognized future income tax assets
|
(11.0 | ) | – | (4.0 | ) | – | ||||||||||
(5.8 | ) | 2.2 | (0.4 | ) | 2.3 | |||||||||||
Earnings
before extraordinary gain
|
16.8 | 6.6 | 9.1 | 8.0 | ||||||||||||
Extraordinary
gain
|
6.2 | – | 2.3 | – | ||||||||||||
Net
earnings for the period
|
23.0 | % | 6.6 | % | 11.4 | % | 8.0 | % | ||||||||
Segmented
information:
|
||||||||||||||||
Sales:
|
||||||||||||||||
Telecom
Division
|
88.2 | % | 86.3 | % | 87.0 | % | 84.2 | % | ||||||||
Life
Sciences and Industrial Division
|
11.8 | 13.7 | 13.0 | 15.8 | ||||||||||||
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||
Earnings
from operations:
|
||||||||||||||||
Telecom
Division
|
7.9 | % | 5.5 | % | 5.0 | % | 4.6 | % | ||||||||
Life
Sciences and Industrial Division
|
1.3 | 1.7 | 1.3 | 2.4 | ||||||||||||
9.2 | % | 7.2 | % | 6.3 | % | 7.0 | % | |||||||||
Research
and development data:
|
||||||||||||||||
Gross
research and development
|
18.2 | % | 16.9 | % | 18.0 | % | 16.5 | % | ||||||||
Net
research and development
|
15.2 | % | 13.6 | % | 14.7 | % | 13.0 | % |
(1)
|
The
cost of sales is exclusive of amortization, shown
separately.
|
Three months
ended
May
31, 2008
|
Three months
ended
May
31, 2007
|
Nine months
ended
May
31, 2008
|
Nine months
ended
May
31, 2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Income
tax provision at combined Canadian federal and provincial statutory tax
rate
|
$ | 1,638,000 | $ | 1,104,000 | $ | 3,618,000 | $ | 3,616,000 | ||||||||
Increase
(decrease) due to:
|
||||||||||||||||
Income
taxed at different rates
|
97,000 | (13,000 | ) | 174,000 | 20,000 | |||||||||||
Non-taxable
income
|
(30,000 | ) | (48,000 | ) | (401,000 | ) | (143,000 | ) | ||||||||
Non-deductible
expenses
|
233,000 | 142,000 | 823,000 | 588,000 | ||||||||||||
Change
in tax rates
|
– | – | 1,522,000 | 290,000 | ||||||||||||
Change
in tax strategy
|
– | – | (2,715,000 | ) | – | |||||||||||
Foreign
exchange effect of translation of foreign integrated
subsidiaries
|
33,000 | (13,000 | ) | 227,000 | 73,000 | |||||||||||
Other
|
(113,000 | ) | (167,000 | ) | 278,000 | (127,000 | ) | |||||||||
Recognition
of previously unrecognized future income tax assets
|
(5,324,000 | ) | – | (5,324,000 | ) | – | ||||||||||
Utilization
of previously unrecognized future income tax assets
|
– | (511,000 | ) | (1,881,000 | ) | (2,510,000 | ) | |||||||||
Unrecognized
future income tax assets on temporary deductible differences and unused
tax losses and deductions
|
686,000 | 379,000 | 3,156,000 | 702,000 | ||||||||||||
Income
tax expense (recovery)
|
$ | (2,780,000 | ) | $ | 874,000 | $ | (523,000 | ) | $ | 2,509,000 |
Expiry
dates
|
Contractual
amounts
|
Weighted
average contractual forward rates
|
||
June
to August 2008
|
$8,800,000
|
1.1154
|
||
September
2008 to March 2010
|
$27,400,000
|
1.0832
|
Stock
Options
|
Number
|
%
of issued and outstanding
|
Weighted
average exercise price
|
|||
Chairman
of the Board, President and CEO
(one
individual)
|
179,642
|
10%
|
$9.05
|
|||
Board
of Directors (five individuals)
|
194,375
|
11%
|
$6.23
|
|||
Management
and Corporate Officers
(eight
individuals)
|
212,139
|
11%
|
$14.49
|
|||
586,156
|
32%
|
$10.08
|
Restricted
Share Units (RSUs)
|
Number
|
%
of issued and outstanding
|
||||
Chairman
of the Board, President and CEO
(one
individual)
|
85,460
|
11%
|
||||
Management
and Corporate Officers
(ten
individuals)
|
238,069
|
30%
|
||||
323,529
|
41%
|
Deferred
Share Units (DSUs)
|
Number
|
%
of issued and outstanding
|
||||
Board
of Directors (five individuals)
|
92,722
|
100%
|
Q3-FY08
|
Q2-FY08
|
Q1-FY08
|
Q4-FY07
|
|||||||||||||
Sales
|
$ | 48,581 | $ | 43,281 | $ | 40,985 | $ | 42,975 | ||||||||
Cost
of sales
|
$ | 19,004 | $ | 18,060 | $ | 18,144 | $ | 18,109 | ||||||||
Gross
margin
|
$ | 29,577 | $ | 25,221 | $ | 22,841 | $ | 24,866 | ||||||||
Earnings
from operations
|
$ | 4,458 | $ | 3,635 | $ | 302 | $ | 9,102 | ||||||||
Earnings
(loss) before extraordinary gain
|
$ | 8,143 | $ | 4,024 | $ | (93 | ) | $ | 33,484 | |||||||
Net
earnings (loss)
|
$ | 11,179 | $ | 4,024 | $ | (93 | ) | $ | 33,484 | |||||||
Basic
earnings (loss) before extraordinary gain
|
$ | 0.12 | $ | 0.06 | $ | (0.00 | ) | $ | 0.49 | |||||||
Diluted
earnings (loss) before extraordinary gain
|
$ | 0.12 | $ | 0.06 | $ | (0.00 | ) | $ | 0.48 | |||||||
Basic
net earnings (loss) per share
|
$ | 0.16 | $ | 0.06 | $ | (0.00 | ) | $ | 0.49 | |||||||
Diluted
net earnings (loss) per share
|
$ | 0.16 | $ | 0.06 | $ | (0.00 | ) | $ | 0.48 |
Q3-FY07
|
Q2-FY07
|
Q1-FY07
|
Q4-FY06
|
|||||||||||||
Sales
|
$ | 39,205 | $ | 35,207 | $ | 35,547 | $ | 35,733 | ||||||||
Cost
of sales
|
$ | 16,828 | $ | 14,970 | $ | 15,229 | $ | 16,318 | ||||||||
Gross
margin
|
$ | 22,377 | $ | 20,237 | $ | 20,318 | $ | 19,415 | ||||||||
Earnings
from operations
|
$ | 2,840 | $ | 2,081 | $ | 2,759 | $ | 2,363 | ||||||||
Net
earnings
|
$ | 2,574 | $ | 2,684 | $ | 3,533 | $ | 2,910 | ||||||||
Basic
and diluted net earnings per share
|
$ | 0.04 | $ | 0.04 | $ | 0.05 | $ | 0.04 |